Lantheus Holdings (LNTH) to Present New Data from First Phase 3 Study of Flurpiridaz F 18 for MPI Patients
Flurpiridaz F 18 301 Phase 3 Study,” will be presented by Rob Beanlands, M.D. of University of Ottawa Heart Institute on Saturday, September 24, … […]